Health ❯ Healthcare

Regulatory Approval

FDA FDA Approval NHS Drug Approval Process European Medicines Agency European Commission Drug Evaluation Clinical Guidelines Medical Device Clearance Health Canada EU Regulations Drug Regulation Xenotransplantation FDA Approvals MHRA Drug Approval Wegovy Approval Process Health Authorities Drug Development Medical Devices

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

The direct-to-consumer launch targets self-pay patients at a $299 starter price to expand choice.

EU Grants Conditional Approval for ImmunityBio’s Anktiva in BCG‑Unresponsive Bladder Cancer

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

FTC Files to Block Edwards Lifesciences’ $945 Million JenaValve Acquisition

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure